PSA testing (men at risk 40 years and older)

  •  Key figures
  •  Data
  •  Graphics
  •  Comments
PROVIDERS & PRESCRIBERS    
Main healthcare providers: Pharmacist biologists 63.00%  
Main prescribers: General practitioners 82.00%  
RATE OF USE    
Average number of interventions (per year) 172,014  
Standardised rate of use (per 100,000 insured persons) 5,899.86  
≥ 2 occurences per patient 2018   1.5%
Percentage of outpatient care 97.54%
POPULATION    
Median age 64 years
Max/min ratio of the median age (by district) 1.13
Percentage of women 0.00%
Ratio Preferential rate/General rate 0.99
TRENDS    
Trend 2012-2019 32.59%
Trend 2017-2019 4.89%
GEOGRAPHICAL VARIATIONS    
Coefficient of variation 2012-2014 64.84  
Coefficient of variation 2017-2019 46.61
Max/min ratio of number of interventions (per 100,000 insured persons, by region) 1.07
Max/min ratio of number of interventions (per 100,000 insured persons, by district) 4.84
DIRECT EXPENDITURE    
Average annual expenditure 469,408  
Average annual expenditure per insured person 0.16  
Max/min ratio of expenditure per insured person (by region) 1.07  
Max/min ratio of expenditure per insured person(by district) 4.84  
Average cost of interventions 2.73  


On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

CODES LABEL CREATION DELETION
433333
433344
Dosage de l'antigène prostatique spécifique (P.S.A.) effectué dans le cadre du dépistage, à partir de 40 ans, chez l'homme présentant des antécédents familiaux de cancer de la prostate diagnostiqué avant l'âge de 65 ans (Maximum 1) (Règle de cumul 338) (Règle diagnostique 97) 01-02-2011
542850
542861
Dosage de l'antigène prostatique spécifique (P.S.A.) par méthode non-isotopique effectué dans le cadre du dépistage individuel, à partir de 40 ans, chez l'homme présentant des antécédents familiaux de cancer de la prostate diagnostiqué avant l'âge de 65 ans (Maximum 1) (Règle de cumul 338) (Règle diagnostique 97) 01-02-2011

The codes mentioned above can be used in rates and expenses, or only in expenses. We invite you to consult the full report for more information.

Below is a graph showing the evolution of the breakdown by volume of nomenclature codes used for the rates:

Dosagedu_hommesde40ansetplus_populationarisque Nomenclature

Men older than or equal to 40 years

 

2019

  • NomenclatureNomenclature codes
  • Age Gender CVAge, gender and CV
  • Patient care settingsPatient care settings
  • Reimbursement rateReimbursement rate
  • TrendsTrends
  • Dot PlotDot Plot
  • MapDistribution map
  • OccurencesOccurences


WE ARE INTERESTED IN YOUR OPINION

Do you have any experience in this area ? We listen to you !

Whether it is on the very validity of the analysis or on the interpretation of the data, a tool has been specially designed to enable you to give your opinion and contact us. Please download the tool below (in French)* and use it to send us the information you wish to send us. Then simply send it by email. This information is valuable to us.

Thank you very much for your interest and collaboration !

Download the tool

*The tool is updated regularly, make sure you have the latest version which is the one available here.


 CONTACT

Send us an email

Download the full report
Download the methodology